|
시장보고서
상품코드
2068945
현장진단 감염병 검사 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 질환 유형별, 기술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Point of Care Infectious Disease Testing Market Size, Share, and Growth Analysis, By Product Type (Rapid Antigen Tests, Molecular Diagnostics Tests), By Disease Type, By Technology, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 현장진단 감염병 검사 시장 규모는 2024년에 128억 달러로 평가되었고, 2025년 135억 9,000만 달러에서 2033년까지 220억 달러로 성장하여 예측 기간(2026-2033년)에 CAGR 6.2%를 기록할 전망입니다.
디지털 헬스케어 생태계의 통합을 통해 검사 결과를 전자 진료 기록, 원격 의료, 분석 플랫폼과 연동함으로써 전 세계 현장 진단(Point-of-Care) 감염병 검사 시장은 눈부신 성장을 이루고 있습니다. 이러한 원활한 상호운용성 덕분에 검사 결과가 양성으로 나올 경우 신속한 원격 치료를 처방할 수 있게 되어, 환자의 내원 횟수를 최소화하고 감염병 발생 상황을 감시하는 체계를 강화하고 있습니다. 병원 네트워크는 업무 흐름의 효율화를 우선시하고, 보험사는 고액의 입원비 절감을 도모하며, 제조업체는 클라우드 연동형 휴대용 기기를 개발하는 등 각 분야에서 혁신이 진행되고 있습니다. 인공지능(AI)은 데이터를 효과적으로 분석하는 머신러닝 모델을 통해 검사 결과 해석을 자동화하고, 검사의 정확도를 높임으로써 매우 중요한 역할을 수행하고 있습니다. 이러한 AI 기반 플랫폼이 발전함에 따라, 현재의 헬스케어 수요에 부응하는 신속하고 신뢰할 수 있는 검사 솔루션을 제공함으로써, 현장 진단(Point-of-Care)을 혁신하고, 환자 치료 수준을 높이며, 시장의 신뢰를 확대되고 있습니다.
세계 현장 진단 감염병 검사 시장의 성장 요인
지역 사회와 병원 환경 모두에서 감염병 발생률이 증가하고 있어 신속한 진단 정보에 대한 수요가 높아지고 있으며, 의료 종사자들은 신속한 결과를 제공하는 현장 진단 솔루션을 도입하고 있습니다. 병원체를 신속하게 규명함으로써, 적시에 치료법을 선택하고, 효과적인 감염 대책을 마련하며, 감염 위험을 줄일 수 있어, 궁극적으로 환자 치료와 업무 효율 향상에 기여합니다. 그 결과, 의료 기관들은 병상, 진료소, 외딴 지역에서 사용하기에 적합한 휴대용 검사 장비에 대한 투자에 주력하고 있습니다. 이러한 변화는 전 세계의 다양한 의료 시스템에서 시장 성장을 주도하는 동시에, 질병 관리를 강화하기 위한 공중보건 정책을 뒷받침하고 있습니다.
세계 현장 진단 감염병 검사 시장의 제약 요인
세계 현장 진단(Point-of-Care) 감염병 검사 시장은 검사 기기의 상용화에 앞서, 치밀한 임상 검증, 종합적인 문서화 및 규정 준수 시험을 요구하는 복잡한 규제 체계로 인해 제약을 받고 있습니다. 이러한 엄격한 요건은 제품 개발 일정을 장기화시키고 막대한 자원의 투입을 필요로 하는 경우가 많아, 승인 획득 가능성에 대한 불확실성을 초래하고 있습니다. 그 결과, 제조업체는 출시 전략을 연기하거나, 제품 라인업을 축소하거나, 더 효율적인 프로세스를 갖춘 시장에 집중하는 등 다양한 선택을 할 수 있으며, 이는 결국 시장 진입 능력을 저해하고 전반적인 성장 가능성을 떨어뜨리게 됩니다. 또한, 이러한 규제 부담 증가는 소규모 혁신 기업 시장 진입을 저해하고, 시장의 발전을 더욱 제한하는 결과로 이어집니다.
세계 현장 진단 감염병 검사 시장 동향
세계 현장 진단(Point-of-Care) 감염병 검사 시장에서는 의료 현장의 실무 변화를 반영하여, 신속한 분자진단 기술의 통합을 향한 뚜렷한 추세가 나타나고 있습니다. 의료 제공업체들은 몇 분 이내에 정확한 감염병 검사 결과를 제공하여 진료 현장에서 즉각적인 의사결정을 가능하게 하는 첨단 신속 분자진단 플랫폼을 점점 더 많이 도입하고 있습니다. 이러한 발전은 신속한 치료 개시의 시급한 필요성, 환자의 대기 시간 단축, 그리고 진료소, 약국, 지역 의료 센터 내에서 감염 확산의 주요 발생지를 효과적으로 관리해야 할 필요성에 힘입어 이루어지고 있습니다. 임상적 및 운영상의 이점이 명확해짐에 따라, 휴대하기 쉽고 사용하기 편리한 검사 기기에 대한 수요가 급증하고 있으며, 이는 다양한 의료 환경에서의 혁신과 확장을 주도하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 현장진단 감염병 검사 시장 규모 : 제품 유형별
세계의 현장진단 감염병 검사 시장 규모 : 질환 유형별
세계의 현장진단 감염병 검사 시장 규모 : 기술별
세계의 현장진단 감염병 검사 시장 규모 : 최종사용자별
세계의 현장진단 감염병 검사 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.07.01Global Point Of Care Infectious Disease Testing Market size was valued at USD 12.8 Billion in 2024 and is poised to grow from USD 13.59 Billion in 2025 to USD 22.0 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).
The integration of digital health ecosystems is driving significant growth in global point-of-care infectious disease testing by connecting test results to electronic records, telemedicine, and analytics platforms. This seamless interoperability allows for prompt remote treatment prescriptions following positive test results, thus minimizing patient visits and enhancing outbreak surveillance. Hospital networks prioritize workflow efficiency, insurers seek to reduce expensive inpatient stays, and manufacturers innovate with portable, cloud-connected devices. Artificial intelligence plays a pivotal role by automating result interpretation and improving test accuracy through machine-learning models that analyze data effectively. As these AI-enhanced platforms evolve, they are transforming point-of-care diagnostics, elevating patient care standards, and expanding market confidence by delivering rapid, reliable testing solutions that align with current healthcare needs.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point Of Care Infectious Disease Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Point Of Care Infectious Disease Testing Market Segments Analysis
Global point of care infectious disease testing market is segmented by product type, disease type, technology, end user and region. Based on product type, the market is segmented into Rapid Antigen Tests, Molecular Diagnostics Tests, Immunoassay-Based Tests and Others. Based on disease type, the market is segmented into Respiratory Infections, Sexually Transmitted Infections (STIs), Healthcare-Associated Infections (HAIs), Tropical & Vector-Borne Diseases, Gastrointestinal Infections, Hepatitis Infections and Others. Based on technology, the market is segmented into Lateral Flow Assays, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification, Microfluidics-Based Testing, Immunoassay Technologies and Others. Based on end user, the market is segmented into Hospitals & Emergency Departments, Clinics & Physician Offices, Diagnostic Laboratories, Ambulatory Care Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Point Of Care Infectious Disease Testing Market
The increasing incidence of infectious diseases in both community and hospital environments creates a heightened need for prompt diagnostic information, leading healthcare professionals to embrace point-of-care solutions that offer rapid results. This swift identification of pathogens allows for timely treatment choices, effective infection control, and a decreased risk of transmission, ultimately improving patient care and operational effectiveness. As a result, healthcare organizations are focusing on investing in portable testing devices suited for bedside use, clinics, and remote areas. This shift is driving market growth across diverse healthcare systems globally while bolstering public health initiatives aimed at enhancing disease management.
Restraints in the Global Point Of Care Infectious Disease Testing Market
The Global Point Of Care Infectious Disease Testing market is hindered by complex regulatory frameworks that demand meticulous clinical validation, comprehensive documentation, and compliance testing prior to the commercialization of testing devices. Such stringent requirements often prolong product development schedules and necessitate significant resource investment, leading to uncertainties about the likelihood of obtaining approvals. As a result, manufacturers may choose to postpone their launch strategies, narrow their product offerings, or focus on markets with more efficient processes, ultimately impeding their ability to penetrate the market and decreasing overall growth potential. This increased regulatory load also deters smaller innovators from entering the field, further limiting market development.
Market Trends of the Global Point Of Care Infectious Disease Testing Market
The Global Point Of Care Infectious Disease Testing market is witnessing a significant trend towards rapid molecular integration, reflecting a growing shift in healthcare practices. Providers are increasingly adopting advanced rapid molecular platforms that offer precise infectious disease results within minutes, facilitating immediate point-of-care decision-making. This evolution is fueled by the urgent need for prompt treatment initiation, diminished patient wait times, and effective management of outbreak hotspots directly within clinics, pharmacies, and community health centers. As the clinical and operational advantages become evident, the demand for portable, user-friendly testing devices is surging, driving innovation and expansion across varied healthcare environments.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Point of Care Infectious Disease Testing Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Rapid Antigen Tests
- Molecular Diagnostics Tests
- Immunoassay-Based Tests
- Others
Global Point of Care Infectious Disease Testing Market Size by Disease Type & CAGR (2026-2033)
- Market Overview
- Respiratory Infections
- Sexually Transmitted Infections (STIs)
- Healthcare-Associated Infections (HAIs)
- Tropical & Vector-Borne Diseases
- Gastrointestinal Infections
- Hepatitis Infections
- Others
Global Point of Care Infectious Disease Testing Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Lateral Flow Assays
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification
- Microfluidics-Based Testing
- Immunoassay Technologies
- Others
Global Point of Care Infectious Disease Testing Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Emergency Departments
- Clinics & Physician Offices
- Diagnostic Laboratories
- Ambulatory Care Centers
- Home Care Settings
- Others
Global Point of Care Infectious Disease Testing Market Size & CAGR (2026-2033)
- North America (Product Type, Disease Type, Technology, End User)
- US
- Canada
- Europe (Product Type, Disease Type, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Disease Type, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Disease Type, Technology, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Disease Type, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cepheid
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OraSure Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chembio Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sekisui Diagnostics, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meridian Bioscience, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nova Biomedical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EKF Diagnostics Holdings plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Visby Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LumiraDx Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Binx Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SD Biosensor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
